[1] Elendu C,John Okah M,Fiemotongha K D J,et al.Comprehensive advancements in the prevention and treatment of diabetic nephropathy:A narrative review[J].Medicine(Baltimore),2023,102(40):e35397. [2] Li X,Lu L,Hou W,et al.Epigenetics in the pathogenesis of diabetic nephropathy[J].Acta Biochim Biophys Sin(Shanghai),2022,54(2):163-172. [3] Dwivedi S,Sikarwar M S.Diabetic nephropathy:Pathogenesis,mechanisms,and therapeutic strategies[J].Horm Metab Res,2025,57(1):7-17. [4] Shen S,Zhong H,Zhou X,et al.Advances in traditional chinese medicine research in diabetic kidney disease treatment[J].Pharm Biol,2024,62(1):222-232. [5] Tang G,Li S,Zhang C,et al.Clinical efficacies,underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management[J].Acta Pharm Sin B,2021,11(9):2749-2767. [6] 郭旭.肾安汤对糖尿病肾病脾肾阳虚证患者血清VEGF、尿KIM-1的影响[D].长沙:湖南中医药大学,2023. Guo X.Effect of Shen’an decoction on serum VEGF and urinary KIM-1 in patients with diabetic nephropathy of spleen-kidney Yang deficiency syndrome[D].Changsha:Hunan University of Chinese Medicine,2023. [7] Yao L,Liang X,Qiao Y,et al.Mitochondrial dysfunction in diabetic tubulopathy[J].Metabolism,2022,131:155195. [8] Takasu M,Kishi S,Nagasu H,et al.The role of mitochondria in diabetic kidney disease and potential therapeutic targets[J].Kidney Int Rep,2024,10(2):328-342. [9] Zhang J,Guo J,Yang N,et al.Endoplasmic reticulum stress-mediated cell death in liver injury[J].Cell Death Dis,2022,13(12):1051. [10] Sankrityayan H,Oza M J,Kulkarni Y A,et al.ER stress response mediates diabetic microvascular complications[J].Drug Discov Today,2019,24(12):2247-2257. [11] Liu Z,Nan P,Gong Y,et al.Endoplasmic reticulum stress-triggered ferroptosis via the XBP1-Hrd1-Nrf2 pathway induces EMT progression in diabetic nephropathy[J].Biomed Pharmacother,2023,164:114897. [12] 郭克磊,李颖利,宣晨光,等.益气养阴化浊通络方通过调控miR-21a-5p/FoxO1/PINK1介导的线粒体自噬减轻糖尿病肾病小鼠的足细胞损伤[J].南方医科大学学报,2025,45(1):27-34. Guo K L,Li Y L,Xuan C G,et al.Yiqi Yangyin Huazhuo Tongluo Formula alleviates diabetic podocyte injury by regulating miR-21a-5p/FoxO1/PINK1-mediated mitochondrial autophagy[J].J South Med Univ,2025,45(1):27-34. [13] 刘雨梦,李姝玉,冯婧,等.肾气丸减轻糖尿病ZDF大鼠的肾损伤研究[J].中国比较医学杂志,2022,32(8):19-26. Liu Y M,Li S Y,Feng J,et al.Effect of Shenqiwan in alleviating renal injury in diabetic ZDF rats[J].Chin J Comp Med,2022,32(8):19-26. [14] Xu X,Zhou B,Liu J,et al.Ru360 alleviates postoperative cognitive dysfunction in aged mice by inhibiting MCU-mediated mitochondrial dysfunction[J].Neuropsychiatr Dis Treat,2023,19:1531-1542. [15] Ruiz-Ortega M,Rodrigues-Diez R R,Lavoz C,et al.Special issue "diabetic nephropathy:Diagnosis,prevention and treatment"[J].J Clin Med,2020,9(3):813. [16] Liang H,Chen S,Zhong J,et al.Dapagliflozin improves diabetic nephropathy by regulating autophagy and ferroptosis through CYP450s/ROS pathway[J].Biochem Pharmacol,2025,240:117134. [17] Rahimi A,Nikooei S,Roozbehi K,et al.Circulating levels of miR-155 and CTBP1-AS2 as a promising biomarker for early detection of diabetic nephropathy[J].Biochem Genet,2025.doi:10.1007/s10528-025-11176-2. [18] Liu X J,Hu X K,Yang H,et al.A review of traditional chinese medicine on treatment of diabetic nephropathy and the involved mechanisms[J].Am J Chin Med,2022,50(7):1739-1779. [19] 胡淑娟,李旭华,刘秀,等.左归降糖益肾方调控miRNA-27a/Wnt/β-catenin通路对糖尿病肾病大鼠的影响及机制[J].中国实验方剂学杂志,2024,30(19):90-97. Hu S J,Li X H,Liu X,et al.Effect and mechanism of Zuogui Jiangtang Yishen prescription on diabetic nephropathy rats by regulating miRNA-27a/Wnt/β-catenin pathway[J].Chin J Exp Tradit Med Form,2024,30(19):90-97. [20] Deng Y,Zhong G,Jin T,et al.Mechanism exploration of Wenshen Jianpi Decoction on renoprotection in diabetic nephropathy via transcriptomics and metabolomics[J].Phytomedicine,2025,139:156446. [21] Mohammad H M F,Galal Gouda S,Eladl M A,et al.Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy[J].Biomed Pharmacother,2023,158:114128. [22] Guo M,Gao J,Jiang L,et al.Astragalus polysaccharide ameliorates renal inflammatory responses in a diabetic nephropathy by suppressing the TLR4/NF-κB pathway[J].Drug Des Devel Ther,2023,17:2107-2118. [23] Yu R,Wu R,Chen T,et al.Yiqi yangyin tongluo recipe alleviates diabetic kidney disease through AGE-RAGE signalling axis[J].Diabetes Metab Syndr Obes,2025,18:2041-2055. [24] Xiong W,Feng J,Liu Y,et al.ShenQiWan ameliorates renal injury in type 2 diabetic mice by modulating mitochondrial fusion and endoplasmic reticulum stress[J].Front Pharmacol,2023,14:1265551. [25] Rosselin M,Santo-Domingo J,Bermont F,et al.L-OPA1 regulates mitoflash biogenesis independently from membrane fusion[J].EMBO Rep,2017,18(3):451-463. [26] Chen H,Zhang H,Li A M,et al.VDR regulates mitochondrial function as a protective mechanism against renal tubular cell injury in diabetic rats[J].Redox Biol,2024,70:103062. [27] Rizk F H,El Saadany A A,Atef M M,et al.Ulinastatin ameliorated streptozotocin-induced diabetic nephropathy:Potential effects via modulating the components of gut-kidney axis and restoring mitochondrial homeostasis[J].Pflugers Arch,2023,475(10):1161-1176. [28] Shu C W,Sun F C,Cho J H,et al.GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis[J].J Cell Physiol,2008,215(3):627-635. [29] Xiong S,Han Y,Gao P,et al.AdipoRon protects against tubular injury in diabetic nephropathy by inhibiting endoplasmic reticulum stress[J].Oxid Med Cell Longev,2020,2020:6104375. [30] 何亚萍,贾登科,陈文英,等.基于线粒体自噬探讨中医药干预糖尿病肾病的研究进展[J].中医药信息,2024,41(11):72-78. He Y P,Jia D K,Chen W Y,et al.Research progress on traditional Chinese medicine intervention in diabetic nephropathy based on mitophagy[J].Inf Tradit Chin Med,2024,41(11):72-78. [31] Beaulant A,Dia M,Pillot B,et al.Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis[J].J Hepatol,2022,77(3):710-722. |